Clinical trials and early detection research are opening new doors for preventing, treating, and ultimately curing type 1 diabetes (T1D).
In this engaging presentation, you’ll hear from Anne Lacey, Dr. Bithika Thompson, and Laura Brigham, Clinical Trial Education Volunteers dedicated to helping our community understand how participation in research can make a real difference.
Don’t miss this opportunity to learn, ask questions, and take a step toward progress for the entire T1D community.
Meet Our Speakers:
Anne Lacey
Anne Lacey was diagnosed with type 1 diabetes at age six and has been involved in clinical research ever since. Following her son Charles’s diagnosis at age two, her family became active participants in research studies, including her daughter, Paxton, taking part in some of the first antibody screenings. With a nursing background and lifelong passion for science, Anne has served on JDRF’s Lay Review Committee, Board of Directors, and in numerous advocacy roles, including currently being the New Mexico Clinical Trials Education Volunteer. Anne remains dedicated to supporting research, participating in clinical trials, and fostering hope for improved therapies and a cure.
Dr. Bithika Thompson
Dr. Bithika Thompson is an adult endocrinologist and Chair of Endocrinology at the Mayo Clinic in Arizona. She was diagnosed with type 1 diabetes at the age of three. She has a special interest in type 1 diabetes technology. Dr. Thompson has served on the board of directors with Breakthrough T1D Desert West since 2016 and is currently the Arizona Clinical Trials Education Volunteer.
Laura Brigham
Laura Brigham has participated in type 1 diabetes clinical trials along with her son since his diagnosis in 2016 at the age of 12. As Nevada’s Breakthrough T1D Clinical Trial Education Volunteer, she helps to spread the word about clinical trial opportunities and the importance of these trials in getting drugs, therapies, and new technologies approved.
